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H.V.CRlnK 
SERUM THERAPY IN THE PREVElJTION AND TREATN®NT OF POLIOMYELITIS 
After.the period of the rapid growth of knowledge 
of poliomyelitis, following the 1907 -1908 epidemics and 
those of the succeeding ten years, the experimental 
investigations, which were directly responsible for the 
accessions, gradually grew less. The reason for tae 
falling off. which occurred almost simultaneously in tae 
United States and in Europe, was that the studies which 
for ten years had been so fruitful ceased to yield 
rewarding results. The beginning of the experimental 
period dates from Landsteiners discovery in 1909 that 
poliomyelitis can be communicated to monkeys by the in-
ocu1ation of human nervous tissue and the determination 
by Flexner and Lewis soon after that indefinite animal to 
animal passage can be secured. It happened that as bhe 
experimeatal investigations declined, the epidemic 
outbreaks also grew less. This coincidence may have 
affected somewhat the zeal with which those investigations 
were persued, because with the return of epidemic waves 
of the disease in America and Eutope in 1927, an inclin-
ation toward renewed study has become apparent~ !he 
return of the severer out-breaks, although localized in 
/ 
1927 in Roumania, Germany, and in Massachusetts and 
California. has oreated anew a feeling of anxiety as to 
whether a more general and serious prevalance may be 
impending. ~his is olearly the feeling in oertain 
looalities in the United States, in oonsequenoe of which 
work has been resumed espeoially at the Rockefeller 
Institute on Immunity and Specific Therapy, the results of 
which follow in this paper. 
No other experimental animal has shown itself 
susoeptible to inoculation with the Virus, or has developed 
specifio anti-bodies on repeated injeotion of virus-
containing Eervous tissues but the monkey. 
The method of use in favor is the combined intra-
meningeal and intravenous injection of human convalescent 
.'- serum. No decision ~s to the best methods in humans has 
.,,-... 
been reaohed. 
Rosenow's and Nuzum'S antiserum prepared by 
injecting streptoooooi will no neutralize the virus of 
poliomyelitis in monkeys. 
,l!'lexner and Amoss showed that large intra-venous doees 
of the virus are ineffeotive in monkeys when the meningeal 
choroid plexns apparatus is intaot. ~hey also showed that 
as long as this intactness oontinues, immune serum does 
not pass from the blood into the oerebro-spinal fluid. 
Now in oases of poliomyelitis in man,even in the mild, 
reoognisable oases, the meningeal ohoroid plexus is ~ 
intaot, a faot shown by the inoreasein the oellular or 
protein content or both of this fluid. When an intra-cerebral 
inoculation of the virus is made in monkeys, not only is a 
lesion produced in the brain at the site of the injection, 
but the virus- carrying salt solution floods the meninges 
and itself produces mild chemical effects which alter the 
intactness. 
On the basis of th~ tests which have been made brief~y 
outlined, it is proposed that human convalescent serum 
should be employed at times of stress and anxiety, when 
poliomyelitis is epidemic, for producing passive immuniaa-
tion. The doses of convalescent serum which is suggested 
are 10 cc. for children and 20 cc. for adults, injected 
subcutaneously and repeated after a period of four to six 
weeks, if the danger still continues. 
If 15 cc. of convalescent ser'm is injected into the 
blood of a monkey twenty four hours before a suitable dose 
of filtered virus is injected intra-cerebrally, infection 
does npt take place. 
The fact has been recognized that the disease is 
one of low incidence and therefore the "efficacy of the 
protective injections will not easily be determined. It 
is beleived that they may be used to diminish anxiety on 
the part of others, but are not of course to take the 
place of the usual precautions exercised to avoid exposure 
to the disease. 
In the passive immunization tests in monkeys, several 
days - called the incubation period of the di~ease- elapse 
between the incubation and the appearance of the first 
symptoms. This period permits the immune anti-bodies to 
become well distributed throughout the nervous system. In 
pre-paralytic or early paralytic poliomyelitis in man, the 
first effects of the virus have taken place, and the next 
events may follow very quickly. There is, therefore, not 
the same period of days or even hours provided for the 
immune bodies in the blood, to reach inconcentration all 
parts of the nervous system. This being the case it would 
seem advisable, theoritically at least, that on. intra-spinal 
injection of the convalescent serum should be given at the 
earliest practical moment. This will insure flooding of 
the nervous tissues with anti-bodies through intermediation 
of the cerebro-spinal fluid, after which the maintainance 
of the anti-body contact may be left to the increased 
permeability of the meningeal choroid plexus barrier to the 
contents of the circulating blood. 
MOae of .J:!.intry. 
£resent opinion is that the virus enters and leaves 
the body by way of the upper respiratory mucous membrane, 
and especially in the secretions of the noso-pharynx. The 
virus has been detected in the secretions and the substance 
of this membrane, both in man and monkey. Moreover,the 
monkey, a relatively resistant species, can be infected by 
, 
merely instilling a virus of sufficient potency into the 
nares. 
The precise path which the virus takes to gain access 
to the brain and spinal cord from the nasal membrane can be 
deduced with tolerable certainty. The virus appears not to 
pass first to the ,blood, through which it is carried to the 
nervous system. Much larger quantities of virus injected 
directly into the blood do not suffice to infect monkeys. 
On the other hand, there are cogent reasons for beleiving 
that the virus ascends along the olfactory nerve filaments 
which unite the mucous membrane of the nose to the olfactory 
lobe of the brain. Probably the descent is also by way of 
these filaments, in the reverse diEection. Since there are 
reasons for beleiving that the virus reaches not only the 
brain but also the cerebro-spinal fluid in the ascent, it 
is likely that the movement upward and dovmward takes place 
in the lymph channels of the nerves t rather than in the axis 
cylinders themselves. Once the brain is reached in this 
movement, the sprea.d of virus may spread by contiguity of 
nervous tissues; but as the early clinical manif'estations 
are oftener paralysis of the extremities than of the bulb, 
it is inferred that the cerebro-spinal fl~id receives the 
virus early. 
However this may be, and whether the virus ascending 
alsong the olfactory nerves, works its way along the brain 
to the more vulnerable spinal cord, or is carried there by 
the cerebra-spinal fluid, it is quite certain that before it 
can strike injuriously it must overcome certain obstacles to 
its penetration. One of these ot,stacles, discovered by Amoss 
and Taylor, resides in the nasal membrane itself; the other, 
determined by Amoss and Flexnor, is bound up with the anat-
omical integrity of the choroid plexus and meninges. If one 
of the obstructive mechanisms fails, the other may still 
operate effectively; but if both fail, the result is 
probably infection and paralysis. Between th~se two there 
appear to be partial failures of the protective mechanisms, 
which may be taken to account for that wide, if not yet 
accurately defined, set of clinical manifestations yielding 
immunity from subclinical and the several clinically abortive 
forms of poliomyelitis now described. 
Since poliom¥elitis is an infectious virus disease, 
from which recovery in whole or in part commonly occurs, it is 
not surpri~ing to discover t in view of the general knowledge 
of the class of virus disease, that recovery results from 
specific immunization in which a rapid production of immune 
bodies takes place. ~hese immune bodies have been deiected 
in the blood as early as the sixth day of acute illness; 
and after recovery from the paralytic disease they have been 
found to persist in the blood in some degree of concentration 
as long as twenty years. Moreover, they are detectable in 
the blood of persons with mild and abortive attacts of 
poliomyelitis and even in So-called normal persons who have 
been suspected Of sub-clinical immunization. This last 
class corresponds of course to other recognized forms of i;J, 
sub-clinical infection,~'g. diptheris, leading not to actual 
illness, but to active immunity. 
With this knowledge of th,e clinical pathology of 
epidemic poliomyelitis before us, we may inquire whether 
the employment already made immune bodies is capable of 
influencing and mederating the experimantal or the natural 
form of the disease. It is apparent that the first step is 
to determine the effect of the immune bodies as represented 
by convalescent serum on monkeys. Thus far it has not been 
fouild possible to produce immune serum in any ani~al other 
than the monkey. Since the virus of poliomyelitis is 
distince from streptococci it seems futile to employ an 
anti-streptococcic serum for specific therapeutic purposes. 
~he prooess as employed by Flexnor,Amoss, and Lewis to 
determine the specific proteotive powers assessed by the 
convalesoent serum was, first, to mix virus and serumoutstde 
the body and injeot the mixture into the brain of monkeys. 
This mode of inoculationris the severest test of infeotivity 
which can be employed. When suitable combinations of serum 
and virus are used, no paralySis results. ?lhen insufficiently 
neutralized virus is used the usual incubation period of the 
experimental disease is prolonged, but ultimately paralysis 
developes. The next procedure is a far more severe test of 
the potency of the convalescent serum. The virus is injected 
into the brain of the monkey. followed by serum injected by 
lumbar puncture into the cerebrospinal fluid. then the virus 
is introduced into the brain, it is deposited into injured 
brain tissue, under conditions favourable for its production 
and. multiplication. A part always passes to the cerebrospinal 
fluid and is carried everywhere in the cerebrospinal axis, 
including of course the vulnerable spinal cord. In this 
experiment it was hoped that the serum placed in the cerebro-
spinal fluid would penetrate the nervous tissues, meet and 
destroy or neutralize the virus. This result has been 
actually achieved. 
By means of these experimental observations was found a 
basis for specific serum therapy of poliomyelitis in man. It 
has now become the reitLe to inject the serum before obvious 
paralYSis occurs. This pre-paralytic stage of pblmomyelitis 
can be detecte by means of accurate labratory methods. 
It has been learned that the virus of poliomyelitis 
passes from the nasal mucosa to the nervous system. It is 
well known that complex chemicals t including protein, do 
not pass from the blood to the cerebrospinal fluid as long as 
the meninges and choroid plexus are anatomically intact. , 
These structures constitute a real barrier between the blood 
and the substance of the brain and cord. »Ut the barrier is 
very sensitively adjusted, and can quite readily be impaired 
by artificial means. The injection of so innocent a fluid as 
Ringer's Solution, and the even more innocent fluid-from 
another monkey of the same species, into the sub-arachnoid 
space, suffices to open the barrier. When the serum is 
injected by lumbar puncture, a marked aseptic meningitis 
is produced and the gates are thrown wide open to the 
constituents of the blood. 
~he effects of this impairment can be shown by placing 
on the nasal mucosa a virus in itself incapable of producing 
poliomyelitis, or injecting into the blood a quantity of 
virus impotent in the normal monkey. In both instances, 
infection and paralysis may follow. 
However, this anatomical and physiological impairment 
of the meninges and choriod plexus may be rendered ineffective 
if convalescent serum is introduced into the spinal fluid. 
~y this means the action of the virus in the nares and the 
blood may be effectively blocked. 
Now, in all cases of symptomatic poliomyelitis now matter 
how mild, changes are probably to be found in the oerebro-
spinal fluid. These changes are signs of inflammation, and 
inflammation indicates a broken barrier. Under these 
circumstances convalescent serum injected into the blood, • 
may pass into the cerebro-spinal fluid and act to prevent and 
stop an impending virus infection. 
Uolvalescent serum introduced into the blood of monkeys 
will prevent an intracerabrai injection of poliomyelitis 
virus from producing paralysis. It is hardly necessary to 
point out the significant application of this observation. 
If in time of danger of epidemic poliomyelitis t adequate 
supplies of human convalescent serum were available, they 
could~doubtless be employed for purposes of passive immun-
ization. 
The specific treatment is carried out by injecting 
the serum into the subarachnoid space and into the blood. 
A question arising at this time is; do the effects of the 
serum so inject~d pass off quickly or are they endured for 
a time. It has been found that when 2 cc. of convalescent 
serum are injected by lumbar puncture, monkeys are protected 
against the intra-cerabral inoculation of the virus for at 
-/- least four days. ...he opinion is therefore, that while the 
first spinal injection is essential, the second may not be 
so, and that the continued presence of immune serum in the 
nervous tissue may be sufficiently provided for by the 
convalescent serum which has been injected into the blood. 
Therapy with Human Serum. 
Serum from persons who have recovered fDom an attact 
of poliomyelitis possesses some power to neutralize the 
virus in vitro. Serum from persons who have been in contact 
with cases of frank poliomyelitis possesses this power in 
equal or greater degree than serum from those who have 
actually been ill. Serum from normal adults never in contact 
wi th known 'cases of the disease seems to possess neutralizing 
power at least equal to that of persons known to have been 
in contact with the aisease. Moreover, normal adult serum 
appears to b' more potent in its action against the virus 
in these in vitro tests than is the serum of convalescents. 
Serum from normal infants between six months and two years 
of age Beems almost devoid of neutralizing powers. 
These results may be thus interpreted: The normal 
infant of a few months of age has no immunity against 
poliomyelitis, but immunity to poliomyelitis gradually 
developes with age so that most adults are immune. Some 
persons are attackeq by the disease ~efore sufficient 
immunity has developed to afford protection. The immunity 
1__ following the attact does not appear to be so great, judging 
,-
by the neutralization test, as the immunity acquired by,the 
"normal" person; this is true also of diptheria. While such 
an hypothesis seems adequate to explain the known facts, it 
remains to be prooved that there is a direct relation between 
immunity to poliomyelitis and the possesion of serum with 
virus neutralizing properties. Aycock's work, as well as that 
of Rhoades and Stewart has prooved that serum from artificially 
immunized monkeys possesses neutralizing properties. The rec~ 
ent work of Aycock and Kramer with serums from the Virgin 
Islands indicates that the virus is distributed as widely in 
areas where the disease is not knows to be endemic as in tee 
United States. This suggests that the factor, which determines \': 
whether the first reaction to the virus is to be immunity or 
int'ection is bound up in peculiarities of the indiv1dual 
.--
attacked. Perhaps the sarne v~riations within the individual 
as those which govern the seasonal incidenoe of the disease. 
These results may prove of praotioal importance in that they 
suggest that the serum of normal adults, properly tested 
beforehand for neutralizing potenoy, may be used therapeuti-
oally with as much promise of releif as when convalescent 
serum is used. Extensive labratory and clinioal investiga-
tionsmust. of oourse, be made before it is certain that a 
serum that neutralizes in vitro will also be effective 
against the virus in vivo. Such a correlation seems to have 
been established for convalescent serum. That this same 
correlation may exist for normal serum from man is indiaated 
by the results of Lingher, who 'got about the same results 
from either serum. 
.. ~ 
Serum Treatment in ~oliomyelitis. 
Experimentally, tne neutralizing or protecting power of 
human immune serum has been conclusively proved. ln 1910 
Levadi ti and Landsteiner, ]'1exner and Lewis, and others 
demonstrated that lee. of human or monkey convalescent serum 
rubbed up with 0.3co. of cord suspension, a fatal dose of 
virus, would neutralize that virus in vitro, in that this 
combined intra-dural implantation in monkeys was not followed 
by the otherwise usual development of the disease. Also 
twenty four hours after the intra-dural injection of a fatal 
dose of virus, 10ce. of convalescent serum given intra-spinally 
likewise protected the monkey from paralysis. Injections of 
serum given later than twenty four nours were not so success-
ful in aborting tne process. These results were at onee 
utilized. as a basis :t:'or serum tnerapy in man. 
The methOd is as ~ollows: 
Blood ~s collected ~rom individuals wno have recovered 
from the disease preferable within a four year period. 
However, dOll.ors with paralysis of 20 years standing were aleo 
,~ used, with no apparent difference in results. The serum is 
carefully separated and inactivated; to it may be added as a 
preservative 0.2 % tri-cresol. In Syracuse, this serum was 
obtained by paying for it. About 2500cs. of blood is usually 
taken from adults and about 100Ces. of clear serum is obtained. 
Administration of the serum is most usually intra-
spinally but may be given by other routes. In brief, the 
/~ dosage and mode of administration for the intra-spinal 
method is as follows: The patient is placed on his side 
with ~is knees drawn up. The back' is prepared with Iodine 
and a; lumbar puncture is done. The spinal fluid is exam-
ined at the bedside with a small portable microscope thus 
confirming the diagnosis. As much fluid as Can be obtained 
is withdrawn. Withdrawal of ~luid may be continuen untill 
definite nuchal pain is oomplained of. If more than 2000s. 
of spinal fluid is obtained, GOocs. of warm serum is intro-
duced by means of a syringe through the lumbar punoture 
needle. Care Should be used not to put the serum in under 
pressure. ~he amounts of serum given vary from 10 to 2500s. 
acoording to the size and age Of the individual. It is now 
beleived that one mistake of the earlier eases was too small 
dosage; 10 ee. in an infant is not too large, and 25 co. 
Should be given to an adult. Sucoessful results have also 
been obtained by giving the serum intravenously or intra-
muscularly". The dosage of' the serum given by these methods 
is the same as by the intra-spinal method. 
Reaotions to the serum treatment are frequent but are 
seldom alarming. The most common reaotion is an increase 
in the meningeal signs, inorEl'ased stif:fness in the neok and 
baok and the presenoe of a Kernig sign. This is accompan-
ied with an increased oell count of the spinal fluid, whion 
-
-, 
may become turbid.. The cellular response does not necessar-
ily parallel the clinical signee The amount of fluid may 
be increased, or decreased at the second puncture. 
The next most common reaction is a chill with a sharp 
rise in temperature, which may reach 105 F. and is frequently 
accompanied by vomiting. This comes on in twenty or thirty 
minutes and is like that during certain transfusions. Whether 
or not blood typing would reduce the frequency of this 
reaction is not known. 
Another reaction is abdominal pain and pain referred to 
the legs after the spinal injection. This is occasionly very 
severe. However, it is usually of Short duration. 
Delayed reactions such as urticaria and arthritis are 
rare if ever present with the human serum injeotion. 
Untoward reactions are rare and those seen conSisted o:f 
marked increase o:f meningeal signs and coma lasting for 24 
or 48 hours. 
The decision for a repeated administration of serum is 
often a'delioate one and much depend.s upon the accuracy of 
observation. In general it is considered gOOd therapy to 
give a second injection if the temperature observations at 
the eighteenth to the twentieth hour shows a fever of 101 F. 
or more. The spinal t~uid is usually clOUdy ±~om the first 
serum and is no true index of aotivity. However,some 
observers advise the serum administration only as the cell 
counts are two hundred or over. The determination by temper-
ature is considered the safest determination. This decision 
should mainly rest with the consultant, who should again see 
the patient at this period. There is rarely the opportunity 
@f a third dose as the patient is either paral1zed or recover~ 
ed after a second. Again, the attending physician must watcn 
his case. Temporization with "waiting till tomorrow" is often 
disastrous. 
In 1916 thirty six early cases were treated with intra-
.spinal serum; nineteen cases sleared without paralysis. Some-
times, due to lack of immediately available human convalescent 
serum, normal human, pneumococcic, and normal horse serum 
were given, and given mainly on an empirical basis, but 
surprizingly, often with equally favourable results. These 
non-specific results and the then reported nigh incidence of 
the abortive case made analysis difIicult and observors at 
this time were somewhat guarded in their opinion, feeling 
that such recoveries might be cOinCidental, but since that 
r--.. time and. mainly by experiEmce here presented, they are now 
convinced as to the value of serum treatment and earnestly 
advise it as the proper procedure in the early period of this 
d.isease. 
Of a series of twenty three cases given anti-pneumocoocic 
serum alone and eight which were given an initial dose of 
of pneumoccic serum and a subsequent dose ot' hu.man convales-
cent serum. As far as can be determined from such a small 
number, there is no great difference in results as compared 
to the human immune serum. This fact is very disturbing, 
since it is non-specific therapy. Little explanation has 
been offered, except that the apparently beneficial results 
may be partially due to the phagocytic action of the additional 
aseptic meningitis produced by this introduction of a foreign 
serum. 
However, it is strongly urged that the human conv~les­
cent serum on the experimental evidence 'be used. It should 
also be remembered that the introduction of pneumococcas 
serum or other non-sp~cific horse serum is often attended 
later by severe reactions with urticaria, joint inflammation 
and acute kidney irritation. Many severe reactions have 
been noted in cases previously sensitized to diptheria toxin 
anti-toxin. Such serum Sickness does not occur with human 
immune serum. For the greater part it has only been used 
when human immune serum was not available. Flexner and Amoss 
showed in the experimental animal, that the intra-spinal 
introduction of horse serum seemed to increase the suscepti-
bility to the virus. 
Serum in the Paralytic Stage. 
The intra-spinal administration of serum to the paralized 
cases is considered:f:'utile, but sometimes decision in the 
early paralytic stage is a difficult one. It is often 
demanded by the parents and attending physician. Paralysis 
well established, cannot be very much a.ffected by serum, 
but in the very early hours 0:1:" paralysis with the temper-
sture remaining high, it has been the plan to examine the 
spinal fluid and if" the cell count is above 200, serum is 
given, this on the premise that if, in the early meningeal 
stage it is of value, then it might also be still of value 
in neutralizing the virus still present and possibly active 
in the surrounding meninges. 
In bulbar types puncture and intra-spinal serum are 
contraindicated. These patients are to be left severely 
alone and must be kept absolutely quiet. With Such quiet , 
they sometimes "slip-by" and the added disturbance by 
puncture and serum might well reverse the bala.nce. 
Intravenous serum is recommended by Amos~ Draper and 
others but is difficult of attainment. It necessitates a 
" 
large amount of serum which is not always available and, in 
the opinion of some, such treatment is not necessary. 
Uonclusions. 
1. That Human convalescent serum offers the best means 
of treatment for epidemic poliomyelitis. 
2. That convalescent serum must be given in the pre-
paralytic stage in order to be of benefit. 
3. ''chat human convalescent serum is the best treatment 
for the prevention of poliomyelitis when the disease is 
endemic. 
4. The initial dosage in infants should be 10cc •• n~ for 
adults 20cc. 
5. That no better method of administration has been 
found than the intraspinal route. 
G. That in the future outbreaks of the disease may be 
successfully treated with human convalescent serum. 
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